in latently infected human lymphoid cells
This is the first of many studies I am going to be sharing that I fear may suddenly "go missing" or be scrubbed from the inter webs at some point.
I've spoken many times of how the rollout of 5g disrupts our body's water structure, and our ability to absorb oxygen. Raditation sickness mimicks flu like symptoms. A lot of what we are seeing as signs/symptoms of CV.
I came across this article and wanted to share as someone who has Epstein Barr. I found it interesting to see a study actually discussing the findings of viruses that have been latent in our bodies being activated by 50 Hz.
The key point I want you to take away from reading this study I've put here, but I'm also highlighting in RED below
This finding provides additional evidence that DNA can be modulated by a magnetic field.
Source linked HERE
Abstract The EBV genome in latently infected lymphoid cells offers an opportunity to follow effects on the transcriptional and translational product clearly distinguishable from those of the host cell genome. Exposure of Akata cells, a human lymphoid cell line latently infected by the EBV genome, to a 50 Hz EMF resulted in an increased number of cells expressing the virus early antigens. This finding provides additional evidence that DNA can be modulated by a magnetic field.
Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals.Bhaduri-McIntosh S, Miller G.J Virol Methods. 2006 Oct;137(1):103-14. doi: 10.1016/j.jviromet.2006.06.006. Epub 2006 Jul 14.PMID: 16843536
Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.Lu CC, Jeng YY, Tsai CH, Liu MY, Yeh SW, Hsu TY, Chen MR.Virology. 2006 Feb 20;345(2):358-72. doi: 10.1016/j.virol.2005.09.064. Epub 2005 Nov 18.PMID: 16298410
Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.AIDS. 2007 Oct 18;21(16):2141-9. doi: 10.1097/QAD.0b013e3282eeeba0.PMID: 18090040
Reactivation of Epstein-Barr virus from latency.Amon W, Farrell PJ.Rev Med Virol. 2005 May-Jun;15(3):149-56. doi: 10.1002/rmv.456.PMID: 15546128 Review.
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Niller HH, Wolf H, Minarovits J.Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772.PMID: 18432410 Review.